FMR CORP 13D and 13G filings for ORIC Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-12 09:30 am Sale |
2024-12-31 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 2,467,809 3.500% |
-1,911,010 (-43.64%) |
Filing |
| 2024-11-12 10:32 am Sale |
2024-11-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 4,378,819 6.207% |
-715,910 (-14.05%) |
Filing |
| 2024-03-11 08:19 am Sale |
2024-03-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 5,094,729 7.562% |
-1,907,379 (-27.24%) |
Filing |
| 2024-02-09 09:28 am Purchase |
2024-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 7,002,108 12.835% |
2,985,500 (+74.33%) |
Filing |
| 2023-02-09 12:01 pm Sale |
2023-02-09 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 4,016,608 10.148% |
-1,890,671 (-32.01%) |
Filing |
| 2022-02-09 10:24 am Purchase |
2022-02-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 5,907,279 14.999% |
454,932 (+8.34%) |
Filing |
| 2021-02-08 10:29 am Purchase |
2021-02-05 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 5,452,347 14.999% |
2,215,014 (+68.42%) |
Filing |
| 2020-05-11 08:45 am Purchase |
2020-05-08 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
FMR CORP | 3,237,333 10.820% |
3,237,333 (New Position) |
Filing |